We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

MAST GROUP

Mast Group is an independent manufacturer and supplier of diagnostic products for clinical, industrial and veterinary... read more Featured Products: More products

Download Mobile App





Mast Awarded Public Health England Tender for Exclusive Supply of AST and AMR Discs

By LabMedica International staff writers
Posted on 08 Oct 2020
Mast Group Ltd. More...
(Liverpool, UK) has been awarded the Public Health England (PHE) tender for the exclusive supply of antibiotic susceptibility (AST) and antimicrobial resistance (AMR) discs.

Mast, a leading European AST manufacturer, is constantly reviewing its portfolio of MASTDISC AST and continues to be at the forefront of development of new antimicrobial discs. As a major strategic partner for pharmaceutical companies, Mast works closely with those organizations on the launch of new compound AST discs, with two already launched this year and more to come in the near future.



Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.